Form 4: Vaxcyte CEO Grant Pickering Reports Stock Transactions
SEC Form 4 Filing
Grant Pickering, CEO of Vaxcyte, reports acquisition of shares through restricted stock units and disposition of shares to cover tax obligations.
Summary
- Grant Pickering, the CEO of Vaxcyte, filed a Form 4 detailing changes in his beneficial ownership of the company's stock.
- On March 27, 2025, he acquired 57,938 shares of common stock through restricted stock units (RSUs) at $0.
- He also disposed of 2,013 shares on February 28, 2025, at $73.02 and 7,984 shares on March 3, 2025, at $72.1 to cover tax withholding obligations related to RSU vesting.
- Following these transactions, Pickering directly owns 498,242 shares and indirectly owns 136,215 shares through a children's trust.
- He also acquired options to purchase 193,431 shares of common stock at an exercise price of $74.22 on February 27, 2025, which vest monthly.
Sentiment
Score: 5
Explanation: The sentiment is neutral as the filing reflects routine stock transactions related to executive compensation.
Industry Context
Form 4 filings are routine disclosures required by the SEC to provide transparency into the transactions of company insiders. They are closely watched by investors to gauge management's sentiment and confidence in the company.
Key Dates
| Date | Description |
|---|---|
| 02/27/2025 | Date of option grant for 193,431 shares. |
| 02/28/2025 | Disposition of 2,013 shares for tax withholding. |
| 03/03/2025 | Disposition of 7,984 shares for tax withholding; Form 4 filing date. |
| 03/27/2025 | Acquisition of 57,938 shares through RSUs; first vesting date for options. |
| 09/07/2025 | First vesting date for 25% of RSU shares. |
| 02/26/2035 | Expiration date of stock options. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.